The Cephalosporin capex (it was small I think but don’t remember the numbers) was announced in FY22. Apart from that company has not undertaken any major capex in the last few years.
2 Likes
Hi, Mridul. Lincon Pharma looks interesting to me. Could you please share the HDFC Sec report you mentioned in the comment? I’m unable to access the report. If you have it, kindly email it to me at adityashaw2604@gmail.com.